Finance

Lists
7780:TPE
Daiken Biomedical Co Ltd
NT$16.15
+1.89%
(+0.30) 1D
Oct 7, 1:30:01 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 7780...
Open
NT$15.80
High
NT$16.15
Low
NT$15.80
Mkt. cap
13.00B
Avg. vol.
743.45K
Volume
805.09K
Dividend
8.30%
Quarterly dividend
NT$0.33
Ex-dividend date
Sep 3, 2026
P/E ratio
29.67
52-wk high
NT$29.40
52-wk low
NT$15.65
EPS
NT$0.54
No. of employees
20
Open
NT$15.80
High
NT$16.15
Low
NT$15.80
Mkt. cap
13.00B
Avg. vol.
743.45K
Volume
805.09K
Dividend
8.30%
Quarterly dividend
NT$0.33
Ex-dividend date
Sep 3, 2026
P/E ratio
29.67
52-wk high
NT$29.40
52-wk low
NT$15.65
EPS
NT$0.54
No. of employees
20
News stories
From web sources and news partners
About Daiken Biomedical Co Ltd
CEO-
Employees20
Founded2018
Headquarters-
SectorPersonal care products
Websitecertifications.nutrasource.ca
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
449.32M
656.11M
463.84M
616.34M
Cost of goods sold
161.39M
254.83M
185.10M
233.80M
Cost of revenue
161.39M
254.83M
185.10M
233.80M
Research and development expenses
2.32M
4.76M
1.90M
2.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
202.66M
272.70M
214.66M
255.28M
Operating expense
204.99M
277.47M
216.56M
257.58M
Total operating expenses
366.38M
532.29M
401.67M
491.38M
Operating income
82.95M
123.82M
62.18M
124.97M
Other non operating income
-
113.00K
629.00K
68.00K
EBT including unusual items
86.03M
152.61M
140.41M
169.67M
EBT excluding unusual items
86.03M
152.61M
140.41M
169.67M
Income tax expense
16.61M
27.97M
36.05M
43.13M
Effective tax rate
19.30%
18.33%
25.68%
25.42%
Other operating expenses
-
-
-
-
Net income
69.42M
124.64M
104.36M
126.54M
Net profit margin
15.45%
19.00%
22.50%
20.53%
Earnings per share
0.11
0.17
-
-
Interest and investment income
2.73M
22.91M
38.45M
45.42M
Interest expense
-108.00K
-468.00K
-827.00K
-643.00K
Net interest expenses
2.62M
22.44M
37.62M
44.78M
Depreciation and amortization charges
-
-
-
-
EBITDA
84.85M
125.64M
63.12M
125.71M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps